Study of the Combination Dostarlimab With Niraparib In Patients With

See also
Status	Clinical Trial	Phase
Completed	`NCT01526486` - Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer	N/A
Completed	`NCT04224740` - Pembrolizumab Combined With Cisplatin-based Chemotherapy as First-line Systemic Therapy in Advanced Penile Cancer	Phase 2
Active, not recruiting	`NCT02496208` - Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors	Phase 1
Recruiting	`NCT04996849` - Contemporary Characteristics of Penile Cancer

See also

Status

Clinical Trial

Phase

Completed

NCT01526486 - Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer

N/A

Completed

NCT04224740 - Pembrolizumab Combined With Cisplatin-based Chemotherapy as First-line Systemic Therapy in Advanced Penile Cancer

Phase 2

Active, not recruiting

NCT02496208 - Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors

Phase 1

Recruiting

NCT04996849 - Contemporary Characteristics of Penile Cancer

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT05526989
Study type	Interventional
Source	H. Lee Moffitt Cancer Center and Research Institute
Contact
Status	Recruiting
Phase	Phase 2
Start date	December 28, 2022
Completion date	October 2026

Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms